Gold(III) Compounds Reveal a Hidden Principle in Topoisomerase Drug Discovery

Top2α CIC IFP

(Based on Sookai et al., Eur. J. Med. Chem. 287 (2025) 117330)

A new publication in the European Journal of Medicinal Chemistry reports a surprising and important discovery about how certain gold(III) compounds interact with human topoisomerase IIα (Top2α)—and the work was made possible using TopoGEN products.

The study reveals that one of these pyrrole-based gold complexes (AuL1) acts as a classic interfacial poison of Top2α, but only within a defined concentration window. At low–mid micromolar levels, AuL1 traps the Top2 cleavage complex effectively, generating abundant linearized DNA. But as concentrations increase, its mechanism flips: the same compound becomes a catalytic inhibitor, blocking enzyme access to DNA entirely.

This biphasic, bell-shaped activity profile is striking—and it underscores a principle TopoGEN has long emphasized:

Single-point drug screens miss critical mechanistic behavior.

A Top2-active compound may appear inactive at one concentration, yet display strong poisoning activity at another. Only through titration-based assays—such as TopoGEN’s industry-standard Top2α relaxation and cleavage complex platforms—can these nuanced modes of action be revealed. The following TopoGEN kits are designed precisely for these types of analyses:

👉 Human Topoisomerase II Assay Kit

👉 Human Topoisomerase II Drug Screening Kit (kDNA Based)

Both kits have variants available with and without Top2α.

As the authors clearly demonstrate, this gold compound shows potent mechanistic switching that would have been invisible in a simple one-dose screen. For anyone developing Top2α targeted therapeutics, this is a powerful reminder: mechanism matters, dose matters, and TopoGEN assays expose what other approaches overlook.

At TopoGEN, we bring over 20 years of topo-focused expertise as a CRO. We can evaluate your compounds across multiple concentrations, distinguish poison vs. catalytic mechanisms, define IC₅₀/EC₅₀ curves, and map subtle interactions that drive real-world drug performance.

Let us help you find your next Top2α drug.

Fast, efficient, affordable TopoGEN services deliver mechanistic clarity—so you can move forward with confidence.
Contact us today for a quote.

 

https://doi.org/10.1016/j.ejmech.2025.117330

Leave a Reply

0
    0
    Your Cart
    Your cart is emptyReturn to Shop